Abiopharma

🔍 Forman Alan S (Director)

Company: JBG SMITH Properties (JBGS)

Report Date: 2026-04-30

Detailed Transactions and Holdings:

• Acquired 18,036 shares of LTIP Units (Derivative)
  Date: 2026-04-30 | Code: A | equity_swap_involved: 0 | shares_owned_after: 101,065.00 | transaction_form_type: 4 | Footnotes: F1, F1, F1, F1, F3, F4

Footnotes:

• F1: The reporting person received a grant of limited partnership units of JBG SMITH Properties LP, JBG SMITH Properties' (the "Issuer's") operating partnership (the "OP"), designated as LTIP Units ("LTIP Units") pursuant to the JBG SMITH Properties 2017 Omnibus Share Plan, as amended. These LTIP Units are a class of units in the OP that are convertible at the option of the holder, conditioned upon minimum allocations to the capital accounts of the LTIP Units for federal income tax purposes, into an equal number of Operating Partnership Units ("OP Units") in the OP. The resulting OP Units are redeemable by the holder for one common share of the Issuer, par value $0.01 (a "Common Share") per OP Unit or the cash value of a Common Share, at the Issuer's option, after the two-year anniversary of the LTIP Units issuance. The LTIP Units will be fully vested on the date of grant but may not be sold while the reporting person serves as a trustee, except in certain circumstances.
• F2: Upon this grant of LTIP Units, the reporting person received corresponding Class B shares of the Issuer, which have no economic rights and are not listed on a stock exchange.
• F3: For each of the LTIP Units beneficially owned by the reporting person, the reporting person holds a corresponding Class B share, which has no economic rights and is not listed on a stock exchange.
• F4: Mr. Forman was previously an employee of Yale University, or Yale. Pursuant to an arrangement between Yale and Mr. Forman, Yale is entitled to receive, as of or prior to the time Mr. Forman ceases to serve as our trustee, certain equity awards granted to Mr. Forman while employed by Yale.